/Companies

AffyImmune Therapeutics

Natick, US · Founded 2016 · Delaware corporation · 1 known investors

Find your way into AffyImmune Therapeutics

Sign up to see every warm intro you have to AffyImmune Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AffyImmune Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

GSGang Song
Gang SongNamed on SEC filingOperating Partner, PhD at ORI Capital
MJ
Moonsoo JinNamed on SEC filing
HF
Hong Fang SongNamed on SEC filing

Investors · 1

Funding

SEC filings, press & company announcements

$7.9M disclosed across 1 of 2 rounds · 2018–2021

▶$7.9MraisedNov 2018 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gang SongExecutive Officer, Director
  • Moonsoo JinExecutive Officer, Director
  • Hong Fang SongDirector
Offering amount
$14.6M
Amount sold
$7.9M
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are AffyImmune Therapeutics's investors?
AffyImmune Therapeutics's investors include ORI Capital.
How much funding has AffyImmune Therapeutics raised?
AffyImmune Therapeutics has disclosed $7.9M raised across 1 of its 2 known rounds.
Where is AffyImmune Therapeutics headquartered?
AffyImmune Therapeutics is headquartered in Natick, US.